GRAHAM CAPITAL MANAGEMENT, L.P. – Alnylam Pharmaceuticals, Inc. Transaction History
GRAHAM CAPITAL MANAGEMENT, L.P. portfolio value:
$2.38M
portfolio value
GRAHAM CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -17.46% | -2.52K shares | 280K | $200.16 | 11.94K |
| Q2 2022 | share | Increase | 0.00% | 14.46K shares | 2.10M | $145.85 | 14.46K |